From Concept to Clinical Practice: A Detailed Review of Total Artificial Heart Devices

Year : 2025 | Volume : | : | Page : –
By
vector

D.V Surya Prakash,

vector

Parnika Vashist,

vector

Palak Priya,

vector

Neha Singh,

vector

Nitika Vats,

  1. Assistant Professor, Department of Biotechnology, Meerut Institute of Engineering and Technology, Uttar Pradesh, India
  2. Student, Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India
  3. Student, Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India
  4. Assistant Professor, Department of Biotechnology, Meerut Institute of Engineering and Technology, Uttar Pradesh, India
  5. Assistant Professor, Department of Biotechnology, Meerut Institute of Engineering and Technology, Uttar Pradesh, India

Abstract

“] document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_146750’);});Edit Abstract & Keyword

Total Artificial Heart (TAH) devices are mechanical systems designed to take over the role of a failing heart in patients with severe heart failure. Unlike ventricular assist devices (VADs), which only support one side of the heart, TAHs replace both ventricles, providing a possible solution for patients who cannot receive a heart transplant. Over time, TAH technology has evolved with a focus on improving biocompatibility, reducing complications related to the device, and improving patient outcomes. However, significant challenges remain, such as long-term durability, infection risks, and the need for ongoing anticoagulation. Despite these obstacles, TAHs have become a vital option for patients awaiting heart transplants or as a temporary solution to recovery. This paper examines the history, technological progress, clinical uses, and future prospects of TAH devices, highlighting their potential to transform heart failure treatment in the future.

Keywords: Artificial, Heart, Treatment, Ventricle, Device.

How to cite this article:
D.V Surya Prakash, Parnika Vashist, Palak Priya, Neha Singh, Nitika Vats. From Concept to Clinical Practice: A Detailed Review of Total Artificial Heart Devices. Research & Reviews : A Journal of Life Sciences. 2025; ():-.
How to cite this URL:
D.V Surya Prakash, Parnika Vashist, Palak Priya, Neha Singh, Nitika Vats. From Concept to Clinical Practice: A Detailed Review of Total Artificial Heart Devices. Research & Reviews : A Journal of Life Sciences. 2025; ():-. Available from: https://journals.stmjournals.com/rrjols/article=2025/view=0

“]document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_146750’);});Edit

References

  1. Fumoto H, Horvath DJ, Rao S, et al. In vivo acute performance of the Cleveland Clinic self-regulating, continuous-flow total artificial heart. J Heart Lung Transplant 2010;29:21-6.
  2. Dowling RD, Gray LA, Jr, Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 2004;127:131-41.
  3. Demondion P, Fournel L, Niculescu M, et al. The challenge of home discharge with a total artificial heart: the La Pitie Salpetriere experience. Eur J Cardiothorac Surg 2013;44:843-8.
  4. Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report–2014; focus theme: retransplantation. J Heart Lung Transplant 2014;33:996-1008.
  5. Thanavaro KL, Tang DG, Cooke RH, et al. Characteristics and survival of patients with the total artificial heart implanted for indications other than biventricular failure. J Heart Lung Transplant 2013;32 suppl 4:S231.
  6. Copeland JG, Smith RG, Arabia FA, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 2004;351:859-67.
  7. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010;139:1316-24.
  8. Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010;105:1030-5.
  9. Kirsch M, Mazzucotelli JP, Roussel JC, et al. Survival after biventricular mechanical circulatory support: does the type of device matter? J Heart Lung Transplant 2012;31:501-8.
  10. Ryan TD, Jefferies JL, Zafar F, et al. The evolving role of the total artificial heart in the management of end-stage congenital heart disease and adolescents. ASAIO J 2015;61:8-14.
  11. Szefner J. Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitié Hospital with patients on total artificial heart. Int J Artif Organs 1995;18:633-48.
  12. DeVries WC. Surgical technique for implantation of the Jarvik-7-100 total artificial heart. JAMA 1988;259:875-80.
  13. Copeland J, Copeland H, Nolan P, et al. Results with an anticoagulation protocol in 99 SynCardia total artificial heart recipients. ASAIO J 2013;59:216-20.
  14. Mankad AK, Tang DG, Clark WB, et al. Persistent anemia after implantation of the total artificial heart. J Card Fail 2012;18:433-8.
  15. Copeland JG, Smith RG, Arabia FA, et al. Total artificial heart bridge to transplantation: a 9-year experience with 62 patients. J Heart Lung Transplant 2004;23:823-31.
  16. Copeland JG, Copeland H, Gustafson M, et al. Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg 2012;143:727-34.
  17. Delgado R, 3rd, Wadia Y, Kar B, et al. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart. J Heart Lung Transplant 2005;24:1166-70.
  18. Levinson MM, Copeland JG, Smith RG, et al. Indexes of hemolysis in human recipients of the Jarvik-7 total artificial heart: a cooperative report of fifteen patients. J Heart Transplant 1986;5:236-48.
Ahead of Print Subscription Review Article
Volume
Received 13/01/2024
Accepted 26/12/2024
Published 09/01/2025
223